Persistence - luck - Avastin

Journal of Clinical Investigation

Volumn 113, Issue 7, 2004, Pages 934-

  Goodman, Laurie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; DRUG APPROVAL; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; HUMAN; NOTE; PRIORITY JOURNAL;

EID: 2142760128     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21507     Document Type: Note

References (3)

1. Ide, A.G., et al. 1939. Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am. J. Roentgenol. 42:891-899.
2. Kim, K.J., et al. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:841-844.
3. Yang, J.C., et al. 2003. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349:427-434.